Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
申请人:Hoffmann-La Roche Inc.
公开号:US09255110B2
公开(公告)日:2016-02-09
Compounds of the formula I or II:
wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.